Search results for: 'workforce identity ad access management'
- Related search terms
- Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026
- Identity and Access Management, 2022
- accessories market size
- Workforce engagement management (WEM) drives performance, agent engagement, and an improved customer experience (CX) in the cont
- identity ad access management market
-
26 Aug 2024  |  Global  |  Market Research
Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029
Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth
The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development. According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040,...
$4,950.00
Special Price $4,207.50 save 15 %
-
14 Sep 2020  |  North America  |  Market Research
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Aug 2020  |  Global  |  Market Research
Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020
Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs
Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...
$3,000.00
Special Price $2,250.00 save 25 %
-
14 Mar 2022  |  North America  |  Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Sep 2019  |  Global  |  Market Research
Growth Insight—Role of AI in the Pharmaceutical Industry, Global, 2018–2022
Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Pharmaceutical Industry
Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Dec 2022  |  North America  |  Market Research
Trends and Growth Indicators for Physician Offices/labs in Decentralized Testing and Services
Personalized Diagnostics Are at the Cusp of Transformational Growth
Accelerated reforms due to COVID-19 and technologically advanced sample-in-answer-out portable, web-connected, encrypted devices that provide results in a few minutes changed the diagnostic healthcare industry. Decentralized testing empowers clinicians to make lifesaving decisions for the patient. It shortens supply chain lag time, saves costs of i...
$2,450.00
Special Price $1,837.50 save 25 %
-
12 Aug 2021  |  North America  |  Frost Radar
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Jun 2024  |  Global  |  Market Research
Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation Global, 2023 2029
A Steady Increase in Laboratory Budgets in Academia is Driving Innovation
This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significa...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Mar 2019  |  North America  |  Market Research
Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022
Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure
Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Oct 2018  |  North America  |  Market Research
US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth
Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...
$1,500.00
Special Price $1,125.00 save 25 %